» Articles » PMID: 32224923

Glutamine Supplementation Prevents Chronic Stress-Induced Mild Cognitive Impairment

Overview
Journal Nutrients
Date 2020 Apr 1
PMID 32224923
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

We recently reported that glutamine (Gln) supplementation protected glutamatergic neurotransmission from the harmful effects of chronic stress. Altered glutamatergic neurotransmission is one of the main causes of cognitive disorders. However, the cognitive enhancer function of Gln has not been clearly demonstrated thus far. Here, we evaluated whether and how Gln supplementation actually affects chronic stress-induced cognitive impairment. Using a chronic immobilization stress (CIS) mouse model, we confirmed that chronic stress induced mild cognitive impairment (MCI) and neuronal damage in the hippocampus. In contrast, Gln-supplemented mice did not show evidence of MCI. To investigate possible underlying mechanisms, we confirmed that CIS increased plasma corticosterone levels as well as brain and plasma levels of reactive oxygen/nitrogen species. CIS also increased levels of inducible nitric oxide synthase and NADPH oxidase subunits (p47 and p67) in both the prefrontal cortex and CA1 region of the hippocampus. CIS decreased the number of synaptic puncta in the prefrontal cortex and hippocampus, but these effects were inhibited by Gln supplementation. Taken together, the present results suggest that Gln is an effective agent against chronic stress-induced MCI.

Citing Articles

Stress-induced mucin 13 reductions drive intestinal microbiome shifts and despair behaviors.

Rivet-Noor C, Merchak A, Render C, Gay N, Beiter R, Brown R Brain Behav Immun. 2024; 119:665-680.

PMID: 38579936 PMC: 11187485. DOI: 10.1016/j.bbi.2024.03.028.


The Role of Glutamine Homeostasis in Emotional and Cognitive Functions.

Baek J, Park H, Kang H, Kim R, Kang J, Kim H Int J Mol Sci. 2024; 25(2).

PMID: 38279303 PMC: 10816396. DOI: 10.3390/ijms25021302.


Neuroprotective effect of (Colebr.) Diels leaf extract on scopolamine-induced memory impairment in rats.

Hawiset T, Sriraksa N, Kamsrijai U, Praman S, Inkaew P Heliyon. 2023; 9(12):e22545.

PMID: 38107289 PMC: 10724565. DOI: 10.1016/j.heliyon.2023.e22545.


Glutamine Supplementation Preserves Glutamatergic Neuronal Activity in the Infralimbic Cortex, Which Delays the Onset of Mild Cognitive Impairment in 3×Tg-AD Female Mice.

Baek J, Kang J, Song M, Lee D, Kim H Nutrients. 2023; 15(12).

PMID: 37375700 PMC: 10303714. DOI: 10.3390/nu15122794.


Regulation of Cortico-Thalamic JNK1/2 and ERK1/2 MAPKs and Apoptosis-Related Signaling Pathways in PDYN Gene-Deficient Mice Following Acute and Chronic Mild Stress.

Yanez-Gomez F, Ramos-Miguel A, Garcia-Sevilla J, Manzanares J, Femenia T Int J Mol Sci. 2023; 24(3).

PMID: 36768626 PMC: 9916432. DOI: 10.3390/ijms24032303.


References
1.
Scheff S, Price D, Schmitt F, DeKosky S, Mufson E . Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology. 2007; 68(18):1501-8. DOI: 10.1212/01.wnl.0000260698.46517.8f. View

2.
Di Meo S, Reed T, Venditti P, Victor V . Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxid Med Cell Longev. 2016; 2016:1245049. PMC: 4960346. DOI: 10.1155/2016/1245049. View

3.
Hanks S, Flood D . Region-specific stability of dendritic extent in normal human aging and regression in Alzheimer's disease. I. CA1 of hippocampus. Brain Res. 1991; 540(1-2):63-82. DOI: 10.1016/0006-8993(91)90493-f. View

4.
Tejada-Simon M, Serrano F, Villasana L, Kanterewicz B, Wu G, Quinn M . Synaptic localization of a functional NADPH oxidase in the mouse hippocampus. Mol Cell Neurosci. 2005; 29(1):97-106. PMC: 2013304. DOI: 10.1016/j.mcn.2005.01.007. View

5.
Son H, Kim S, Jung D, Baek J, Lee D, Roh G . Insufficient glutamine synthetase activity during synaptogenesis causes spatial memory impairment in adult mice. Sci Rep. 2019; 9(1):252. PMC: 6342969. DOI: 10.1038/s41598-018-36619-2. View